NASDAQ:NTLA - Intellia Therapeutics SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$15.73 -0.09 (-0.57 %)
(As of 12/17/2018 04:43 AM ET)
Previous Close$15.73
Today's Range$15.49 - $16.15
52-Week Range$15.49 - $35.99
Volume364,927 shs
Average Volume463,040 shs
Market Capitalization$682.98 million
P/E Ratio-8.37
Dividend YieldN/A
Beta3.88

SEC Filings

Intellia Therapeutics (NASDAQ:NTLA) SEC Filings

DateFilerForm TypeView
12/06/2018
6:45 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/01/2018
5:37 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/31/2018
4:58 PM
GOODMAN JESSE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/31/2018
4:57 PM
GOODMAN JESSE (Reporting)
Intellia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
10/31/2018
8:01 AM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
10/31/2018
6:47 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/29/2018
7:37 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
10/29/2018
4:10 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/12/2018
4:29 PM
Intellia Therapeutics (Filer)
Form S-3ASR
View Filing
08/10/2018
3:44 PM
HAYES JOHN T. (Reporting)
Intellia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
08/01/2018
6:46 AM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/01/2018
6:30 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/20/2018
3:31 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/18/2018
7:40 AM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
3:06 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/20/2018
11:03 AM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/21/2018
3:15 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/21/2018
11:59 AM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/21/2018
11:56 AM
Intellia Therapeutics (Issuer)
KARSEN PERRY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/21/2018
11:54 AM
DORSA CAROLINE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/21/2018
11:51 AM
Intellia Therapeutics (Issuer)
Verwiel Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/17/2018
9:47 AM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/15/2018
7:43 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/02/2018
3:35 PM
Intellia Therapeutics (Issuer)
SCHIERMEIER ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/01/2018
6:46 AM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/01/2018
6:30 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/01/2018
6:15 AM
Intellia Therapeutics (Filer)
Form 10-K/A
View Filing
04/27/2018
3:06 PM
Intellia Therapeutics (Issuer)
SCHIERMEIER ANDREW (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
04/17/2018
6:30 AM
Intellia Therapeutics (Filer)
Form DEF 14A
View Filing
04/17/2018
6:15 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/30/2018
9:20 AM
Bell Graeme (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/26/2018
4:12 PM
DORSA CAROLINE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/23/2018
4:29 PM
Intellia Therapeutics (Issuer)
NOVARTIS AG (Reporting)
Novartis Institutes for BioMedical Research, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
03/23/2018
4:27 PM
Intellia Therapeutics (Subject)
Novartis Institutes for BioMedical Research, Inc. (Filed by)
Form SC 13D/A
View Filing
03/22/2018
12:43 PM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2018
7:04 AM
Intellia Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/14/2018
6:40 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/16/2018
12:25 PM
Intellia Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
View Filing
02/06/2018
3:07 PM
Caribou Biosciences, Inc. (Filed by)
Intellia Therapeutics (Subject)
Form SC 13G/A
View Filing
01/30/2018
4:28 PM
Caribou Biosciences, Inc. (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2018
4:24 PM
Intellia Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
View Filing
01/29/2018
2:32 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2018
2:31 PM
Bell Graeme (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2018
2:30 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/18/2017
6:46 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/14/2017
3:07 PM
Bermingham Nessan (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2017
3:06 PM
Bell Graeme (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2017
11:29 AM
Intellia Therapeutics (Subject)
Novartis Institutes for BioMedical Research, Inc. (Filed by)
Form SC 13D/A
View Filing
12/14/2017
11:19 AM
Intellia Therapeutics (Issuer)
NOVARTIS AG (Reporting)
Novartis Institutes for BioMedical Research, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/08/2017
4:27 PM
Bermingham Nessan (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
This page was last updated on 12/17/2018 by MarketBeat.com Staff

Featured Article: Quiet Period

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel